Get the Stockscreener App
0.00
100.00%
-0.86
After Hours:
.8719
0.8719
+
Acelrx Pharmaceuticals Inc Stock (ACRX) Forecast
The Acelrx Pharmaceuticals Inc (ACRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $29.90, representing a + increase from the current price of $0.00. The highest analyst price target is $37.20, and the lowest is $22.59.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACRX Price Target
Average 18.72
(+ Upside)
Is Acelrx Pharmaceuticals Inc (ACRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 19.88 | Buy |
| STOCH(9,6) | 42.67 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0338 | Sell |
| ADX(14) | 32.87 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -466.67 | Sell |
Buy: 2
Sell: 4
Neutral: 1
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7037
Sell
|
0.6453
Sell
|
| MA20 |
0.7289
Sell
|
0.6936
Sell
|
| MA50 |
0.6571
Sell
|
0.6951
Sell
|
| MA100 |
0.7089
Sell
|
0.7458
Sell
|
| MA200 |
0.8133
Sell
|
0.9239
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ACRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 14 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on ACRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 19.88 indicates that ACRX is oversold. This indicates that ACRX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 42.67 indicates that ACRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that ACRX is oversold. This suggests that ACRX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.87 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -466.67 indicates that ACRX is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ACRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acelrx Pharmaceuticals Inc financial reports and earnings history, Acelrx Pharmaceuticals Inc (ACRX) stock could reach $11.18 by 2030, $23.40 by 2040 and $82.01 by 2050. See the projected annual prices until 2050 of the Acelrx Pharmaceuticals Inc stock below:
- Acelrx Pharmaceuticals Inc (ACRX) is expected to reach an average price of $4.4122 in 2035, with a high prediction of $5.466 and a low estimate of $4.4122. This indicates an $ rise from the last recorded price of $0.00.
- Acelrx Pharmaceuticals Inc (ACRX) stock is projected to chart a bullish course in 2040, with an average price target of $22.31, representing an $ surge from its current level. The forecast ranges from a conservative $22.44 to a sky-high $23.40.
- Our analysts predict Acelrx Pharmaceuticals Inc (ACRX) to jump by 2045, soaring from $46.12 to an average price of $45.64, potentially reaching $49.30. While $46.12 is the low estimate, the potential upside is significant.
- Acelrx Pharmaceuticals Inc (ACRX) stock is expected to climb by 2050, reaching an average of $81.84, a $ jump from its current level. However, a wide range of estimates exists, with high and low targets of $82.01 and $82.18, respectively, highlighting the market's uncertainty.
Acelrx Pharmaceuticals Inc Stock (ACRX) Year by Year Forecast
Acelrx Pharmaceuticals Inc Stock (ACRX) Price Forecast for 2024
Our forecast for ACRX stock price in 2024 now indicates an average price target of $19.09 with a high forecast of $37.77 and a low forecast of $0.4064. The average prediction reflects an increase of + from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $30.55 | $22.59 | $37.20 | + |
| June, 2024 | $9.7684 | $8.9684 | $31.31 | + |
| July, 2024 | $7.7354 | $1.018 | $11.74 | + |
| August, 2024 | $11.55 | $5.2888 | $19.29 | + |
| September, 2024 | $6.716 | $1.316 | $11.90 | + |
| October, 2024 | $4.9296 | $4.1296 | $16.58 | + |
| November, 2024 | $5.5432 | $1.3958 | $5.8364 | + |
| December, 2024 | $4.2898 | $0.65 | $6.0966 | + |
Acelrx Pharmaceuticals Inc Stock (ACRX) Price Forecast for 2025
Acelrx Pharmaceuticals Inc Stock (ACRX) is expected to reach an average price of $7.1097 in 2025, with a high prediction of $13.98 and a low estimate of $0.2442. This indicates an + rise from the last recorded price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.9238 | $0.2742 | $12.72 | + |
| February, 2025 | $4.1374 | $4.784 | $11.83 | + |
| March, 2025 | $1.4956 | $0.2442 | $6.0908 | + |
| April, 2025 | $6.682 | $3.7422 | $5.656 | + |
| May, 2025 | $11.07 | $12.47 | $13.98 | + |
| June, 2025 | $1.7014 | $5.1014 | $11.71 | + |
| July, 2025 | $2.8878 | $5.5946 | $2.748 | + |
| August, 2025 | $5.4742 | $5.9344 | $3.581 | + |
| September, 2025 | $6.7072 | $8.1208 | $8.0606 | + |
| October, 2025 | $5.0936 | $7.4936 | $7.9538 | + |
| November, 2025 | $7.68 | $6.6334 | $5.68 | + |
| December, 2025 | $2.913 | $2.2198 | $12.38 | + |
Acelrx Pharmaceuticals Inc Stock (ACRX) Price Forecast for 2026
The predicted value for Acelrx Pharmaceuticals Inc (ACRX) in 2026 is set at an average of $15.98. Estimates vary from a peak of $31.95 to a trough of $0.0042, indicating an + surge from the present price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.9006 | $3.1472 | $12.39 | + |
| February, 2026 | $1.7142 | $0.146 | $10.05 | + |
| March, 2026 | $2.5188 | $0.379 | $2.7744 | + |
| April, 2026 | $10.89 | $0.8586 | $31.49 | + |
| May, 2026 | $16.51 | $11.25 | $31.95 | + |
| June, 2026 | $7.4754 | $3.8152 | $19.77 | + |
| July, 2026 | $1.311 | $1.311 | $8.7822 | + |
| August, 2026 | $0.856 | $0.0042 | $7.842 | + |
| September, 2026 | $3.8696 | $0.3906 | $9.3162 | + |
| October, 2026 | $2.0832 | $0.4832 | $6.9764 | + |
| November, 2026 | $0.8502 | $0.19 | $7.8366 | + |
| December, 2026 | $0.9362 | $0.2896 | $1.557 | + |
Acelrx Pharmaceuticals Inc Stock (ACRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acelrx Pharmaceuticals Inc (ACRX) is $5.9014, with a high forecast of $10.83 and a low forecast of $0.9692. This indicates an + increase from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.9226 | $1.3226 | $0.6294 | + |
| February, 2027 | $2.449 | $0.9692 | $0.3692 | + |
| March, 2027 | $6.898 | $3.1416 | $5.342 | + |
| April, 2027 | $8.2384 | $7.4126 | $7.0824 | + |
| May, 2027 | $8.7854 | $8.375 | $7.7614 | + |
| June, 2027 | $9.9198 | $9.6546 | $8.4198 | + |
| July, 2027 | $9.3862 | $9.6722 | $9.441 | + |
| August, 2027 | $10.97 | $10.72 | $10.66 | + |
| September, 2027 | $10.96 | $11.11 | $10.83 | + |
| October, 2027 | $10.74 | $11.12 | $10.77 | + |
| November, 2027 | $10.97 | $10.54 | $10.39 | + |
| December, 2027 | $9.3414 | $9.2662 | $8.8216 | + |
Acelrx Pharmaceuticals Inc Stock (ACRX) Price Forecast for 2028
In 2028, Acelrx Pharmaceuticals Inc (ACRX) is projected to reach an average price of $6.9651, with a high projection of $8.9326 and a low estimate of $4.9976. This indicates an + rise from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.8124 | $7.9304 | $8.9326 | + |
| February, 2028 | $6.9988 | $7.1122 | $6.7322 | + |
| March, 2028 | $7.9452 | $7.4134 | $7.5186 | + |
| April, 2028 | $8.7116 | $7.7564 | $8.5016 | + |
| May, 2028 | $8.1946 | $8.3346 | $8.7048 | + |
| June, 2028 | $7.901 | $7.9744 | $7.9912 | + |
| July, 2028 | $7.214 | $7.1774 | $7.4776 | + |
| August, 2028 | $7.0404 | $6.8972 | $6.9506 | + |
| September, 2028 | $6.7968 | $6.8702 | $6.8571 | + |
| October, 2028 | $6.5173 | $6.6084 | $6.7891 | + |
| November, 2028 | $5.8262 | $5.9662 | $6.2192 | + |
| December, 2028 | $4.9526 | $4.9976 | $5.5517 | + |
Acelrx Pharmaceuticals Inc Stock (ACRX) Price Forecast for 2029
The 2029 price forecast for Acelrx Pharmaceuticals Inc Stock (ACRX) is $22.01 on average, with a high prediction of $43.83 and a low estimate of $0.1852. This represents an + increase from the previous price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.9156 | $4.1356 | $4.5492 | + |
| February, 2029 | $3.572 | $3.612 | $3.7165 | + |
| March, 2029 | $2.8984 | $3.1204 | $3.3997 | + |
| April, 2029 | $2.5507 | $2.5681 | $2.745 | + |
| May, 2029 | $2.0473 | $2.0478 | $2.398 | + |
| June, 2029 | $1.5312 | $1.5508 | $1.852 | + |
| July, 2029 | $0.4986 | $0.4986 | $1.321 | + |
| August, 2029 | $45.53 | $0.1852 | $43.83 | + |
| September, 2029 | $40.31 | $39.12 | $38.41 | + |
| October, 2029 | $24.97 | $30.57 | $39.69 | + |
| November, 2029 | $25.74 | $21.16 | $23.74 | + |
| December, 2029 | $18.61 | $20.22 | $16.72 | + |
Acelrx Pharmaceuticals Inc Stock (ACRX) Price Forecast for 2030
Acelrx Pharmaceuticals Inc Stock (ACRX) is expected to reach an average price of $26.03 in 2030, with a high forecast of $42.66 and a low forecast of $9.3972. This signifies an + surge from the last price of $0.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.78 | $9.3972 | $11.18 | + |
| February, 2030 | $37.36 | $29.58 | $30.96 | + |
| March, 2030 | $33.53 | $35.93 | $34.45 | + |
| April, 2030 | $32.60 | $27.92 | $28.60 | + |
| May, 2030 | $33.17 | $36.49 | $34.18 | + |
| June, 2030 | $34.34 | $29.65 | $31.66 | + |
| July, 2030 | $32.81 | $33.91 | $33.53 | + |
| August, 2030 | $42.18 | $35.99 | $37.78 | + |
| September, 2030 | $30.05 | $32.25 | $39.47 | + |
| October, 2030 | $34.62 | $31.34 | $30.53 | + |
| November, 2030 | $37.39 | $36.11 | $36.39 | + |
| December, 2030 | $49.66 | $39.48 | $42.66 | + |
1.69%
1.28%
Cap:
|
Volume (24h):